[GYNECOLOGY].
D000033:Abortion, Threatened; D001201:Ascites; D002200:Capillary Resistance; D004715:Endometriosis; D004964:Estriol; D004967:Estrogens; D005260:Female; D005833:Genital Neoplasms, Female; D006026:Glycoside Hydrolases; D006049:Gold Isotopes; D012739:Gonadal Steroid Hormones; D006062:Gonadotropins; D006176:Gynecology; D006801:Humans; D008593:Menopause; D009369:Neoplasms / Q000532:radiotherapy*; D009640:Norethindrone; D009641:Norethynodrel; D010051:Ovarian Neoplasms; D011085:Polycystic Ovary Syndrome; D011247:Pregnancy; D011276:Pregnanediol; D011374:Progesterone; D011372:Progestins; D014596:Uterine Prolapse
D004967:Estrogens; D006049:Gold Isotopes; D012739:Gonadal Steroid Hormones; D006062:Gonadotropins; D011372:Progestins; D011374:Progesterone; D009641:Norethynodrel; D006026:Glycoside Hydrolases; D004964:Estriol; D011276:Pregnanediol; D009640:Norethindrone
ABORTION, THREATENED; ASCITES; CAPILLARY RESISTANCE; ENDOMETRIOSIS; ESTRIOL; ESTROGENS; GLYCOSIDE HYDROLASES; GOLD ISOTOPES; GONADOTROPINS; GYNECOLOGIC NEOPLASMS; GYNECOLOGY; MENOPAUSE; NEOPLASM RADIOTHERAPY; NORETHINDRONE; NORETHYNODREL; OVARIAN NEOPLASMS; PREGNANEDIOL; PROGESTATIONAL HORMONES; PROGESTERONE; REVIEW; SEX HORMONES; STEIN-LEVENTHAL SYNDROME; UTERINE PROLAPSE
GYN'ECOLOGIE.